029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD901不同分期膀胱癌组织芯片,附TNM和临床分期,90例/90点
点 数90例 数90
行 数9列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD901
 
不同分期膀胱癌组织微阵列芯片,包含61例尿路上皮癌,13例鳞状细胞癌,14例腺癌,2例小细胞癌(其中I期10例,II期25例,III期55例),一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIB)
TISSUE  ARRAYS UBD901
1
2
3
4
5
6
7
8
9
10
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
I
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1145FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A2272MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
A3342MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
A4450MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
A5570MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
A6682FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
A7745FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
A8878FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
A9965MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
A101077FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
B11125FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
B21279FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
B31371MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B41456FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
B51543FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
B61666MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant3*3*2N
B71758MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
B81870MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*2.5*2.5N
B91950FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
B102082MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
C12161MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
C22256MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
C32342MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*5*4N
C42474FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
C52555MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
C62670FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C72737FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
C82867MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
C92942MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
C103070MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
D13170MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
D23235MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D33348MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D43469MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D53572MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D63655MBladderLow-grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
D73772MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
D83845FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
D93956MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
D104060FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant5.0N
E14174MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E24257FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
E34367MBladderHigh grade urothelial carcinoma (interstitial)*T3N0M0IIIAMalignant7*4*3N
E44467MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E54554FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant3.5*3.0*1N
E64665FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant4*3*2N
E74760MBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant3*2*2N
E84870FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant*N
E94972MBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant12*12*5N
E105071MBladderHigh grade urothelial carcinoma with necrosis (sparse)*T3bN0M0IIIAMalignant8*7N
F15168MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F25260FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2*2N
F35345MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F45453MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant5*4*2N
F55553MBladderUrothelial carcinoma*T3bN0M0IIIAMalignant11*8*4N
F65668MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F75733MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F85853MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F95940FBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F106052MBladderHigh grade urothelial carcinoma*T4aN0M0IIIAMalignant*N
G16155MBladderHigh grade urothelial carcinoma*T4N0M0IIIAMalignant6*4*3N
G26275MBladderSquamous cell carcinoma*T2N1M0IIIAMalignant*N
G36351MBladderSquamous cell carcinoma*T3aM0N0IIIAMalignant*N
G46468MBladderSquamous cell carcinoma2T3aN0M0IIIAMalignant6*3.5*3N
G56567MBladderSquamous cell carcinoma2T3aN0M0IIIAMalignant4*4*3.5N
G66668MBladderSquamous cell carcinoma2T3bN0M0IIIAMalignant6*5.5N
G76746FBladderSquamous cell carcinoma2T3N0M0IIIAMalignant*N
G86866FBladderSquamous cell carcinoma2T3N1M0IIIAMalignant*N
G96951MBladderSquamous cell carcinoma2T2bN2M0IIIBMalignant*N
G107072MBladderSquamous cell carcinoma2--3T3bN0M0IIIAMalignant6*4*3N
H17157MBladderSquamous cell carcinoma3T3aN0M0IIIAMalignant*N
H27252MBladderSquamous cell carcinoma3T3N0M0IIIAMalignant*N
H37365MBladderSquamous cell carcinoma3T3bN0M0IIIAMalignant6*4N
H47451MBladderSquamous cell carcinoma (sparse)3T4aN1M0IIIAMalignant4*3*3N
H57560MBladderAdenocarcinoma2T2N1M0IIIAMalignant*N
H67648FBladderAdenocarcinoma with degenerate2T3N0M0IIIAMalignant10*6*3N
H77770MBladderAdenocarcinoma2T3N0M0IIIAMalignant*N
H87858MBladderAdenocarcinoma with necrosis2T3N1M0IIIAMalignant*N
H97946FBladderAdenocarcinoma2T3bN2M0IIIBMalignant*N
H108032MBladderMucinous adenocarcinoma2T3N0M0IIIAMalignant5*4*4N
I18176MBladderAdenocarcinoma2--3T4N0M0IIIAMalignant*N
I28243MBladderAdenocarcinoma3T3aM0N0IIIAMalignant10*7*6N
I38365MBladderAdenocarcinoma3T3bN0M0IIIAMalignant3*1.5N
I48450MBladderAdenocarcinoma3T3N0M0IIIAMalignant6*5*2.5N
I58553MBladderAdenocarcinoma3T3N1M0IIIAMalignant*N
I68665MBladderAdenocarcinoma3T4N0M0IIIAMalignant2.5*1.5*1N
I78753FBladderMucinous adenocarcinoma3T3N0M0IIIAMalignant*N
I88857MBladderUndifferentiated carcinoma*T2N1M0IIIAMalignant*N
I98950FBladderSmall cell carcinoma*T2N1M0IIIAMalignant*N
I109049FBladderSmall cell carcinoma*T3N1M0IIIAMalignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情